Beyond Inc

GB2855930

Equity

ISIN US6903701018 / Valor 1390596

New York Stock Exchange, Inc (2024-12-24)

USD 4.84-0.41%

Beyond Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Beyond Inc is a technology company that specializes in developing innovative solutions for the healthcare industry.

Summarized from source with an LLMView SourceSector: Consumer Services

Revenue Decline

Beyond Inc. reported total net revenue of $398 million for the second quarter of 2024, which represents a decrease of 5.7% year-over-year. Despite the decline, the company has been focusing on improving its operational efficiencies and customer engagement.

Gross Profit

For the second quarter of 2024, Beyond Inc. achieved a gross profit of $80 million, which is 20.1% of the total net revenue. This marks a significant step in improving the company's gross margin profile, as highlighted by the management.

Net Loss

Beyond Inc. reported a net loss of $43 million for the second quarter of 2024. The diluted net loss per share stood at $0.93, while the adjusted diluted net loss per share (non-GAAP) was $0.76. The company is actively working on reducing its fixed costs to improve profitability.

Adjusted EBITDA

In the second quarter of 2024, Beyond Inc. reported an adjusted EBITDA (non-GAAP) of negative $36 million, which represents -9.1% of net revenue. This is a 25% sequential improvement, indicating progress in the company's efforts to enhance its financial performance.

Active Customers

Beyond Inc. saw a significant increase in its active customer base, reaching 6.2 million in the second quarter of 2024, a 35% increase year-over-year. This growth reflects the company's successful strategies in customer acquisition and retention.

Summarized from source with an LLMView Source

Key figures

-82.7%1Y

-92.3%3Y

-22.8%5Y

Performance

78.9%1Y

77.6%3Y

90.3%5Y

Volatility